ArthroCare And Smith & Nephew Resolve Litigation Via Distribution Deal
This article was originally published in The Gray Sheet
ArthroCare will manufacture bipolar and monopolar arthroscopy products that Smith & Nephew Endoscopy will sell worldwide as part of an agreement to end litigation between the two companies
You may also be interested in...
An injunction against sales of Smith & Nephew arthroscopy devices found to infringe 16 ArthroCare patents will not be delayed by S&N's appeal under an April 27 court ruling, ArthroCare says
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.